Blockchain Registration Transaction Record
Oncotelic Advances CNS Drug Delivery with $12.5M Deal
Oncotelic Therapeutics (OTLC) completes $12.5M monetization of N2B CNS delivery system with Lunai Bioworks for Alzheimer's and biodefense. CNS drug delivery breakthroughs drive biotech market opportunities.
This news matters because the blood-brain barrier is a major hurdle in treating neurological diseases like Alzheimer's. Oncotelic's platform and partnership could accelerate development of therapies that effectively reach the brain, potentially improving outcomes for millions of patients. For investors, it highlights a growing biotech niche focused on delivery solutions, which could see increased valuation as the market recognizes the importance of BBB penetration.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0xb063dc6a07f660e8989b6a5ab272138962e06f5054d744f9c28fb14fea6cde3c |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | wamcP5Vy-69a4b1a86c22283c58336f7e89842f26 |